Patent ID: 11918638
Assignee: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 5:
6. The recombinant RSV of claim 1, which exhibits:
reduced expression of the NS1 gene and/or NS2 gene compared to an RSV having the NS1 gene in gene position 1 and the NS2 gene in gene position 2;
reduced transcription of the NS1 gene and/or NS2 gene compared to an RSV having the NS1 gene in gene position 1 and the NS2 gene in gene position 2; and/or
reduced inhibition of host interferon response compared to an RSV having the NS1 gene in gene position 1 and the NS2 gene in gene position 2.